3,3'-diaminobenzidine has been researched along with Lymph Node Metastasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, L; Motosugi, U; Murata, S; Nagata, K; Sakurai, T; Sannohe, S; Shimizu, M; Shimizu, Y; Yamaguchi, H; Yasuda, M | 1 |
| Glass, LF; Messina, JL | 1 |
| Ansai, S; Aoki, T; Hozumi, Y; Kondo, S; Koseki, S; Mitsuhashi, Y | 1 |
3 other study(ies) available for 3,3'-diaminobenzidine and Lymph Node Metastasis
| Article | Year |
|---|---|
Detection of lymphatic invasion in resected cases of primary pancreatic cancer based on immunohistochemistry of D2-40.
Topics: 3,3'-Diaminobenzidine; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Humans; Immunohistochemistry; Lymphatic Metastasis; Pancreatic Neoplasms; Staining and Labeling | 2009 |
Pathologic examination of the sentinel lymph node.
Topics: 3,3'-Diaminobenzidine; Chemotherapy, Adjuvant; Chromogenic Compounds; Coloring Agents; Disease-Free Survival; General Surgery; Humans; Immunohistochemistry; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Medical Oncology; Melanoma; Neoplasm Staging; Nuclear Medicine; Pathology; Patient Care Team; Prognosis; S100 Proteins; Skin Neoplasms; Survival Rate | 1997 |
An immunohistochemical study of E-cadherin expression in human squamous cell carcinoma of the skin: relationship between decreased expression of E-cadherin in the primary lesion and regional lymph node metastasis.
Topics: 3,3'-Diaminobenzidine; Antibodies, Monoclonal; Cadherins; Carcinoma, Squamous Cell; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphatic Metastasis; Prognosis; Skin Neoplasms | 1999 |